Dr. Paul grew up in NYC, attended Harvard College and completed her medical and graduate training at Mount Sinai Medical School.
Academic interests include community outreach, asthma prevention and management, wound healing and resident education.
Regional / National Committees / Advisory Boards:
Past Chair, Section on Pediatric Emergency Medicine, ACEP
Chair, Micro-site Advisory Board, Pediatric Emergency Medicine ACEP
EMSC, National Resource Center
SAEM, Social Media Committee
Supersprowtz Advisory Board
Pediatric Emergency Medicine
MD, Mount Sinai Hospital
Mount Sinai Hospital
Fellowship, Pediatric Emer Med
Columbia University Medical Center
Bela Shick Award in Pediatrics
AOA Hirschhorn Pediatrics Award
Research interests include adverse behavioral effects of steroids in treatment of pediatric asthma, ED management of pediatric UTI, resident education.Also interested in utilization of child life in pediatric and adult emergency medicine departments
Zelicof-Paul A, Lockridge-Smith A, Schnadower D, E. Controversies in rapid sequence intubation in children. Curr Opin Pediatr 2005 June; 17(3): 355-362.
Zelicof A, Protopopov V, E. Two Separate Functions are Encoded by the Carboxyl-terminal domains of the Yeast Adenylyl Cyclase Associated Protein and its Mammalian Homologs;Dimerization and Actin Binding. Journal of Biological Chemistry 1996; 271(30): 18243-18253.
Zelicof A, Gatica J, Gerst JE. Molecular Cloning and Characterization of a Mammalian Homolog of CAP-the adenylyl cyclase associated Protein from S.Cerevisae. Journal of Biological Chemistry 1993; 268(18): 13448-13453.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Paul did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.